Global Market for Non-Invasive Prenatal Testing is Anticipated to grow at a Significant Pace i.e., USD 19.21 Billion during the Forecast Period 2021-2027

The global Non-Invasive Prenatal Testing Market is anticipated to grow at 16.35% CAGR during the forecast period. Factors attributing to the growth of the Non-Invasive Prenatal Testing Market include the rising prominence of SSIs, rising number of surgical procedures, technological development of innovating new products, significant increase in the occurrence of complications from HAIs, and rising geriatric population. Nevertheless, the growing initiatives by government and rising number of collaborations by key industry players will create opportunities for growth of the Non-Invasive Prenatal Testing Market.

Download PDF Brochure @ https://www.vynzresearch.com/healthcare/non-invasive-prenatal-testing-market/request-sample

3M is on the mission to protect patients from preventable surgical site infections (SSIs) as they believe that up to 5% of patients undergoing surgery may have negative consequences of an SSI, as patients might have an increased length of stay in hospital that can impact the quality of life. So they are committed to using their best practices and evidence-based solutions to reduce the risk of SSIs in the facility

The COVID-19 outbreak has had a negative impact on Non-Invasive Prenatal Testing Market owing to decrease in funding of R&D activities associated with surgical site infection control agents and decrease in number of elective surgeries will adversely affect the market.

By product, antibiotic prophylaxis contributes to the largest share in the Non-Invasive Prenatal Testing Market in 2020.

Read Full Research Report Description at https://www.vynzresearch.com/healthcare/non-invasive-prenatal-testing-market/request-sample

Based on product, the Non-Invasive Prenatal Testing Market is segmented into wound care dressings, antibiotic prophylaxis products, clippers, surgical drapes, antiseptics and disinfectants, surgical staff clothing, patient-warming products, wound irrigation products, wound care supplementary products, and others. Antibiotic prophylaxis dominates the market owing to the increased cost of antibiotics, acceptance of antibiotics as the most established preventive method for surgical site infections, and patient-friendly dosage forms like tablets, capsules, etc.

Asia-Pacific is expected to be the fastest-growing region in the Non-Invasive Prenatal Testing Market owing to increasing patient pool, increased awareness by government organizations, abd rising prominence of surgical site infections.

Some of the major players in the Non-Invasive Prenatal Testing Market include 3M Company, Medtronic plc, Mölnlycke Health Care AB, B. Braun Melsungen AG, Covalon Technologies Ltd., Stryker Corporation, Becton, Dickinson and Company, Prescient Surgical Inc., Surgical Site Infection Prevention LLC, and STERIS plc.

Buy directly to this Research Report at https://www.vynzresearch.com/buy_report/TVRReQ==/YzJsdVoyeGxYM1Z6WlhKZmJHbGpaVzV6WlE9PQ==

Contact Us:

VynZ Research
Call: +91-996-028-8381
Toll-Free (U.S. and Canada): +1-888-253-3960
Email: enquiry@vynzresearch.com

About VynZ Research

VynZ Research is a market research firm offering research, analytics, and consulting services on business strategies. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. VynZ Research assists enterprises to take strategic decisions for helping their businesses to grow. The reports developed by VynZ are based on market facts that include comprehensive analysis and quantification of market drivers, industry dynamics, opportunities, challenges, threats, market shares and anticipated new trends & technologies arising across a wide range of industries.

This release was published on openPR.